MedPath

â??A Clinical Study to check the Safety and efficacy of HSBP-121901 in babies

Phase 2
Registration Number
CTRI/2022/06/043588
Lead Sponsor
Himalaya wellness company
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

. Babies in the age group between 0 to 36 months inclusive of both age and genders

. Babies in general good health as determined from a recent medical history and the pediatrician.

. Baby mother/legal representative preferably mother willing to give a voluntary written informed consent and agree to come for regular follow up.

. Baby mother/legal representative, preferably mother willing to abide by and comply with the study protocol.

. Babies should not participate in any other clinical study during participation in the current study.

. Babies delivered after complete gestation ( > 38 weeks).

Exclusion Criteria

. Babies with a known history or present condition of allergic response to any other Diapers, toiletries or its components or ingredients as in the test product.

. Babies with diarrhea/ bowel incontinence

. Babies with diaper rashes or any allergies in the diaper area.

. Any pre-existing systemic disease necessitating long term medications and other dermatological problems.

. Babies requiring incubators/ ventilators or C-PAP.

. Babies who have participated in a similar clinical investigation in the past four weeks.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath